Döhner, H., Symeonidis, A., Deeren, D., Demeter, J., Sanz, M. A., Anagnostopoulos, A., Esteve, J., Fiedler, W., Porkka, K., Kim, H., Lee, J., Usuki, K., D'Ardia, S., Won Jung, C., Salamero, O., Horst, H., Recher, C., Rousselot, P., Sandhu, I., Theunissen, K., Thol, F., Döhner, K., Teleanu, V., DeAngelo, D. J., Naoe, T., Sekeres, M. A., Belsack, V., Ge, M., Taube, T., & Ottmann, O. G. (2021). adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial. HemaSphere, 5(8), e617–. http://access.bl.uk/ark:/81055/vdc_100145478947.0x000014